Paper33718985
Chronic Myelogenous Leukemia in Childhood.
Smith SM and 2 others. Curr Oncol Rep, 2021. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Chronic Myelogenous Leukemia in Childhood. Papers, record 33718985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33718985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Adolescent | |
| Child | |
| Dasatinib | |
| Hematopoietic Stem Cell Transplantation | |
| Humans | |
| Imatinib Mesylate | |
| Pyrimidines | |
| Remission Induction |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18591451 | Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. | Circulation | 2008 | https://conductscience.org/library/papers/18591451 | PubMed |
| 2 | 32734668 | A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia. | Br J Haematol | 2020 | https://conductscience.org/library/papers/32734668 | PubMed |
| 3 | 15537917 | Oligospermia in a patient receiving imatinib therapy for the hypereosinophilic syndrome. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15537917 | PubMed |
| 4 | 23147254 | The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics. | Leukemia | 2013 | https://conductscience.org/library/papers/23147254 | PubMed |
| 5 | 23365461 | Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A. | Blood | 2013 | https://conductscience.org/library/papers/23365461 | PubMed |
| 6 | 29925908 | Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. | Leukemia | 2018 | https://conductscience.org/library/papers/29925908 | PubMed |
| 7 | 29874142 | New Agents, Emerging Late Effects, and the Development of Precision Survivorship. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29874142 | PubMed |
| 8 | 30168243 | Temporal trends in the proportion of "cure" in children, adolescents, and young adults diagnosed with chronic myeloid leukemia in England: A population-based study. | Pediatr Blood Cancer | 2018 | https://conductscience.org/library/papers/30168243 | PubMed |
| 9 | 12006504 | Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. | Clin Cancer Res | 2002 | https://conductscience.org/library/papers/12006504 | PubMed |
| 10 | 32127639 | European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. | Leukemia | 2020 | https://conductscience.org/library/papers/32127639 | PubMed |
| 11 | 28905209 | Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls. | Clin Transl Oncol | 2018 | https://conductscience.org/library/papers/28905209 | PubMed |
| 12 | 26371140 | Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26371140 | PubMed |
| 13 | 29899367 | Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia. | Leukemia | 2018 | https://conductscience.org/library/papers/29899367 | PubMed |
| 14 | 39976936 | The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review. | JAMA Oncol | 2025 | https://conductscience.org/library/papers/39976936 | PubMed |
| 15 | 30944100 | The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia. | Blood Adv | 2019 | https://conductscience.org/library/papers/30944100 | PubMed |
| 16 | 21298759 | Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy. | Pediatr Blood Cancer | 2011 | https://conductscience.org/library/papers/21298759 | PubMed |
| 17 | 30267760 | Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30267760 | PubMed |
| 18 | 32668374 | Ponatinib in childhood Philadelphia chromosome-positive leukaemias: an international registry of childhood chronic myeloid leukaemia study. | Eur J Cancer | 2020 | https://conductscience.org/library/papers/32668374 | PubMed |
| 19 | 25459396 | Growth deceleration in children treated with imatinib for chronic myeloid leukaemia. | Eur J Cancer | 2014 | https://conductscience.org/library/papers/25459396 | PubMed |
| 20 | 22052850 | Imatinib has adverse effect on growth in children with chronic myeloid leukemia. | Pediatr Blood Cancer | 2012 | https://conductscience.org/library/papers/22052850 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42548712 | Case Report: Chronic myeloid leukemia masquerading as essential thrombocythemia in a child: the imperative for early BCR::ABL1 testing in isolated thrombocytosis. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42548712 | PubMed |
| 42352456 | Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42352456 | PubMed |
| 39682300 | Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682300 | PubMed |
| 39005125 | Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/39005125 | PubMed |
| 37284518 | Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review. | Pediatric Health Med Ther | 2023 | https://conductscience.org/library/papers/37284518 | PubMed |
| 36948878 | [Study progress of tyrosine kinase inhibitor discontinuation in children with chronic myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | https://conductscience.org/library/papers/36948878 | PubMed |
| 35689379 | Penttinen syndrome-associated PDGFRB Val665Ala variant causes aberrant constitutive STAT1 signalling. | J Cell Mol Med | 2022 | https://conductscience.org/library/papers/35689379 | PubMed |
| 35531147 | Protective effect of Bosutinib with caspase inhibitors on human K562 cells. | Saudi J Biol Sci | 2022 | https://conductscience.org/library/papers/35531147 | PubMed |
| 34918996 | Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. | Pediatr Hematol Oncol | 2022 | https://conductscience.org/library/papers/34918996 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33718985
GET https://conductscience.org/api/papers/v1/33718985/references?page=2